Giuffre Randall Michael 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Giuffre Randall Michael
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-01+32,162→ 32,162 totalExercise: $4.11Exp: 2035-05-31→ Common Shares (32,162 underlying)
Holdings
- 392,412
Voting Common Shares, no par value per share
- 21,070(indirect: By Spouse)
Voting Common Shares, no par value per share
- 25,573(indirect: See footnote)
Voting Common Shares, no par value per share
Footnotes (3)
- [F1]Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 95,016 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 128,360 voting common shares held by Michael Giuffre individually.
- [F2]These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power.
- [F3]Vests in four nearly equal quarterly installments over one year.